[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |
Advanced search

Cancer Biomarkers Market: Global Market Size, Forecast, Insights, and Competitive Landscape

December 2022 | 157 pages | ID: CEEC691B1B40EN
Prodture

US$ 2,299.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
The global cancer biomarkers market is expected to grow at a CAGR of around 10.1% during 2023-2030. This report on global cancer biomarkers market report provides holistic understanding of the market along with market sizing, forecast, drivers, challenges, and competitive landscape. The report presents a clear picture of the global cancer biomarkers market by segmenting the market based on type, biomolecule movement, application movement, and region. Also, detailed profiles of companies operating in the cancer biomarkers market are provided in this report. We believe that this report will aid the professionals and industry stakeholders in making informed decision.

Market Drivers
  • Increasing Government Funding for Cancer Research
  • Growing Popularity of Personalized Medicine
  • Technological Advancements
Market Challenges
      • Technical Issues Related to Sample Collection and Storage
  • Lack of Clarity in Proving Clinical Validity
Historical & Forecast Period

Base Year: 2022

Historical Period: 2018-2022

Forecast Period: 2023-2030

Market by Type
  • Breast Cancer
  • Prostate Cancer
  • Colorectal Cancer
  • Cervical Cancer
  • Liver Cancer
  • Lung Cancer
  • Others
Market by Biomolecule
  • Genetic Biomarkers
  • Epigenetic Biomarkers
  • Metabolic Biomarkers
  • Proteomic Biomarkers
  • Others
Market by Application
  • Drug Discovery
  • Diagnostics
  • Personalized Medicine
  • Online Stores
  • Others
Market by Region
  • Europe
    • Germany
    • United Kingdom
    • France
    • Italy
    • Spain
    • Russia
    • Netherlands
    • Rest of Europe
  • North America
    • United States
    • Canada
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Australia
    • Indonesia
    • Rest of Asia Pacific
  • Latin America
    • Mexico
    • Brazil
    • Argentina
    • Rest of Latin America
  • Middle East & Africa
    • Saudi Arabia
    • Turkey
    • Iran
    • United Arab Emirates
    • Rest of Middle East & Africa
1. PREFACE

1.1 Objective
1.2 Target Audience & Key Offerings
1.3 Report’s Scope
1.4 Research Methodology
  1.4.1 Phase I
  1.4.2 Phase II
  1.4.3 Phase III
1.5 Assumptions

2. KEY INSIGHTS

3. GLOBAL CANCER BIOMARKERS MARKET

3.1. Introduction
3.2. Market Drivers
3.3. Market Challenges

4. GLOBAL CANCER BIOMARKERS MARKET ANALYSIS

4.1. Market Portraiture
4.2. Market Size
4.3. Market Forecast
4.4. Impact of COVID-19

5. GLOBAL CANCER BIOMARKERS MARKET BY TYPE

5.1. Introduction
5.2. Breast
5.3. Prostate
5.4. Colorectal
5.5. Cervical
5.6. Liver
5.7. Lung
5.8. Others

6. GLOBAL CANCER BIOMARKERS MARKET BY BIOMOLECULE

6.1 Introduction
6.2 Genetic
6.3 Epigenetic
6.4 Metabolic
6.5 Proteomic
6.6 Others

7. GLOBAL CANCER BIOMARKERS MARKET BY APPLICATION

7.1 Introduction
7.2 Drug Discovery
7.3 Diagnostics
7.4 Personalized Medicine
7.5 Online Stores
7.6 Others

8. GLOBAL CANCER BIOMARKERS MARKET BY REGION

8.1 Introduction
8.2 Europe
  8.2.1 Germany
  8.2.2 United Kingdom
  8.2.3 France
  8.2.4 Italy
  8.2.5 Spain
  8.2.6 Russia
  8.2.7 Netherlands
  8.2.8 Rest of the Europe
8.3 North America
  8.3.1 United States
  8.3.2 Canada
8.4 Asia Pacific
  8.4.1 China
  8.4.2 Japan
  8.4.3 India
  8.4.4 South Korea
  8.4.5 Australia
  8.4.6 Indonesia
  8.4.7 Rest of the Asia Pacific
8.5 Latin America
  8.5.1 Mexico
  8.5.2 Brazil
  8.5.3 Argentina
  8.5.4 Rest of Latin America
8.6 Middle East & Africa
  8.6.1 Saudi Arabia
  8.6.2 Turkey
  8.6.2 Iran
  8.6.3 United Arab Emirates
  8.6.4 Rest of Middle East & Africa

9. SWOT ANALYSIS

10. PORTER’S FIVE FORCES

11. MARKET VALUE CHAIN ANALYSIS

12. COMPETITIVE LANDSCAPE

12.1 Competitive Scenario
12.2 Company Profiles
  12.2.1 Abbott Laboratories
  12.2.2 F. Hoffmann-La Roche Ltd.
  12.2.3 Qiagen N.V
  12.2.4 Affymetrix Inc.
  12.2.5 Illumina, Inc.
  12.2.6 Agilent Technologies
  12.2.7 Merck & Co. Inc.
  12.2.8 Hologic, Inc.
  12.2.9 Sino Biological Inc.
  12.2.10 B Thermo Fisher Scientific Inc.
  12.2.11 Becton, Dickinson and Company


LIST OF TABLES

Table 1: Global Cancer Biomarkers Market Portraiture
Table 2: Global Cancer Biomarkers Market by Type (in US$ Million), 2022 & 2030
Table 3: Global Cancer Biomarkers Market by Biomolecule (in US$ Million), 2022 & 2030
Table 4: Global Cancer Biomarkers Market by Application (in US$ Million), 2022 & 2030
Table 5: Global Cancer Biomarkers Market by Region (in US$ Million), 2022 & 2030
Table 6: Europe Cancer Biomarkers Market by Country (in US$ Million), 2022 & 2030
Table 7: North America Cancer Biomarkers Market by Country (in US$ Million), 2022 & 2030
Table 8: Asia Pacific Cancer Biomarkers Market by Country (in US$ Million), 2022 & 2030
Table 9: Latin America Cancer Biomarkers Market by Country (in US$ Million), 2022 & 2030
Table 10: Middle East & Africa Cancer Biomarkers Market by Country (in US$ Million), 2022 & 2030
Table 11: List of Key Players

LIST OF FIGURES

Figure 1: Global Cancer Biomarkers Market (in US$ Million), 2018-2022
Figure 2: Global Cancer Biomarkers Market by Type, 2022
Figure 3: Global Cancer Biomarkers Market by Biomolecule, 2022
Figure 4: Global Cancer Biomarkers Market by Application, 2022
Figure 5: Global Cancer Biomarkers Market by Region, 2022
Figure 6: Global Cancer Biomarkers Market (in US$ Million), 2023-2030
Figure 7: Global Cancer Biomarkers Market by Type (in %), 2022 & 2030
Figure 8: Global Breast Cancer Biomarkers Market (in US$ Million), 2018-2022
Figure 9: Global Breast Cancer Biomarkers Market (in US$ Million), 2023-2030
Figure 10: Global Prostate Cancer Biomarkers Market (in US$ Million), 2018-2022
Figure 11: Global Prostate Cancer Biomarkers Market (in US$ Million), 2023-2030
Figure 12: Global Colorectal Cancer Biomarkers Market (in US$ Million), 2018-2022
Figure 13: Global Colorectal Cancer Biomarkers Market (in US$ Million), 2023-2030
Figure 14: Global Cervical Cancer Biomarkers Market (in US$ Million), 2018-2022
Figure 15: Global Cervical Cancer Biomarkers Market (in US$ Million), 2023-2030
Figure 16: Global Liver Cancer Biomarkers Market (in US$ Million), 2018-2022
Figure 17: Global Liver Cancer Biomarkers Market (in US$ Million), 2023-2030
Figure 18: Global Lung Cancer Biomarkers Market (in US$ Million), 2018-2022
Figure 19: Global Lung Cancer Biomarkers Market (in US$ Million), 2023-2030
Figure 20: Global Cancer Biomarkers Market by Biomolecule Movement (in %), 2022 & 2030
Figure 21: Global Genetic Cancer Biomarkers Market (in US$ Million), 2018-2022
Figure 22: Global Genetic Cancer Biomarkers Market (in US$ Million), 2023-2030
Figure 23: Global Epigenetic Cancer Biomarkers Market (in US$ Million), 2018-2022
Figure 24: Global Epigenetic Cancer Biomarkers Market (in US$ Million), 2023-2030
Figure 25: Global Metabolic Cancer Biomarkers Market (in US$ Million), 2018-2022
Figure 26: Global Metabolic Cancer Biomarkers Market (in US$ Million), 2023-2030
Figure 27: Global Proteomic Cancer Biomarkers Market (in US$ Million), 2018-2022
Figure 28: Global Proteomic Cancer Biomarkers Market (in US$ Million), 2023-2030
Figure 29: Global Other Cancer Biomarkers Market (in US$ Million), 2018-2022
Figure 30: Global Other Cancer Biomarkers Market (in US$ Million), 2023-2030
Figure 31: Global Cancer Biomarkers Market by Application Movement (in %), 2022 & 2030
Figure 32: Global Drug Discovery Cancer Biomarkers Market (in US$ Million), 2018-2022
Figure 33: Global Drug Discovery Cancer Biomarkers Market (in US$ Million), 2023-2030
Figure 34: Global Diagnostics Cancer Biomarkers Market (in US$ Million), 2018-2022
Figure 35: Global Diagnostics Cancer Biomarkers Market (in US$ Million), 2023-2030
Figure 36: Global Personalized Medicine Cancer Biomarkers Market (in US$ Million), 2018-2022
Figure 37: Global Personalized Medicine Cancer Biomarkers Market (in US$ Million), 2023-2030
Figure 38: Global Other Cancer Biomarkers Market (in US$ Million), 2018-2022
Figure 39: Global Other Cancer Biomarkers Market (in US$ Million), 2023-2030
Figure 40: Global Cancer Biomarkers Market by Region (in %), 2022 & 2030
Figure 41: Europe Cancer Biomarkers Market (in US$ Million), 2018-2022
Figure 42: Europe Cancer Biomarkers Market (in US$ Million), 2023-2030
Figure 43: Europe Cancer Biomarkers Market by Country (in %), 2022 & 2030
Figure 44: Germany Cancer Biomarkers Market (in US$ Million), 2018-2030
Figure 45: United Kingdom Cancer Biomarkers Market (in US$ Million), 2018-2030
Figure 46: France Cancer Biomarkers Market (in US$ Million), 2018-2030
Figure 47: Italy Cancer Biomarkers Market (in US$ Million), 2018-2030
Figure 48: Spain Cancer Biomarkers Market (in US$ Million), 2018-2030
Figure 49: Russia Cancer Biomarkers Market (in US$ Million), 2018-2030
Figure 50: Netherlands Cancer Biomarkers Market (in US$ Million), 2018-2030
Figure 51: North America Cancer Biomarkers Market (in US$ Million), 2018-2022
Figure 52: North America Cancer Biomarkers Market (in US$ Million), 2023-2030
Figure 53: North America Cancer Biomarkers Market by Country (in %), 2022 & 2030
Figure 54: United States Cancer Biomarkers Market (in US$ Million), 2018-2030
Figure 55: Canada Cancer Biomarkers Market (in US$ Million), 2018-2030
Figure 56: Asia Pacific Cancer Biomarkers Market (in US$ Million), 2018-2022
Figure 57: Asia Pacific Cancer Biomarkers Market (in US$ Million), 2023-2030
Figure 58: Asia Pacific Cancer Biomarkers Market by Country (in %), 2022 & 2030
Figure 59: China Cancer Biomarkers Market (in US$ Million), 2018-2030
Figure 60: Japan Cancer Biomarkers Market (in US$ Million), 2018-2030
Figure 61: India Cancer Biomarkers Market (in US$ Million), 2018-2030
Figure 62: South Korea Cancer Biomarkers Market (in US$ Million), 2018-2030
Figure 63: Australia Cancer Biomarkers Market (in US$ Million), 2018-2030
Figure 64: Indonesia Cancer Biomarkers Market (in US$ Million), 2018-2030
Figure 65: Latin America Cancer Biomarkers Market (in US$ Million), 2018-2022
Figure 66: Latin America Cancer Biomarkers Market (in US$ Million), 2023-2030
Figure 67: Latin America Cancer Biomarkers Market by Country (in %), 2022 & 2030
Figure 68: Mexico Cancer Biomarkers Market (in US$ Million), 2018-2030
Figure 69: Brazil Cancer Biomarkers Market (in US$ Million), 2018-2030
Figure 70: Argentina Cancer Biomarkers Market (in US$ Million), 2018-2030
Figure 71: Middle East & Africa Cancer Biomarkers Market (in US$ Million), 2018-2022
Figure 72: Middle East & Africa Cancer Biomarkers Market (in US$ Million), 2023-2030
Figure 73: Middle East & Africa Cancer Biomarkers Market by Country (in %), 2022 & 2030
Figure 74: Saudi Arabia Cancer Biomarkers Market (in US$ Million), 2018-2030
Figure 75: Turkey Cancer Biomarkers Market (in US$ Million), 2018-2030
Figure 76: Iran Cancer Biomarkers Market (in US$ Million), 2018-2030
Figure 77: UAE Cancer Biomarkers Market (in US$ Million), 2018-2030
Figure 78: Market Value Chain

More Publications

Need Help?

Ask a Question

Market Reports

All Categories